Pages that link to "Q36290407"

The following pages link to Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients (Q36290407):

Displaying 23 items.

• Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis (Q28070039) (← links)
• The monocyte to red blood cell count ratio is a strong predictor of postoperative survival in colorectal cancer patients: The Fujian prospective investigation of cancer (FIESTA) study. (Q33702312) (← links)
• Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis (Q33762053) (← links)
• Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies (Q33762117) (← links)
• Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis (Q33765560) (← links)
• Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis (Q36054506) (← links)
• Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis (Q36189355) (← links)
• Prognostic value of inflammation-based scores in patients with osteosarcoma (Q37529300) (← links)
• Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. (Q37629061) (← links)
• The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis (Q37746223) (← links)
• Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies. (Q38369552) (← links)
• An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis. (Q39327275) (← links)
• Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases (Q39815313) (← links)
• Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis (Q40435555) (← links)
• The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer (Q43547409) (← links)
• Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis (Q46101818) (← links)
• Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study. (Q55289894) (← links)
• Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis. (Q55398000) (← links)
• Prognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy (Q58801937) (← links)
• Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis (Q59791060) (← links)
• Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients (Q60934751) (← links)
• Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study (Q90257491) (← links)
• Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer (Q90706525) (← links)